| ID | Name | Organism | Chains bound to carbohydrates |
|---|---|---|---|
| 1 | omalizumab variant C02 VH Heavy chain subclass: IGHV3 |
Homo sapiens | 2 chains bound to carbohydrates Chain A [auth E]: 1 glycosylation head interface 1 N-glycosylation Chain D [auth C]: 1 glycosylation head interface 2 glycosylation body interfaces 1 N-glycosylation |
| 2 | omalizumab variant C02 VL Light chain subclass: IGKV1 (Kappa) |
Homo sapiens | 0 chain bound to carbohydrates |
| 3 | Immunoglobulin heavy constant epsilon P01854 (IGHE_HUMAN) |
Homo sapiens | 2 chains bound to carbohydrates Chain C [auth B]: 2 glycosylation head interfaces 3 glycosylation body interfaces 1 unassigned-glycosylation Chain F [auth A]: 1 glycosylation body interface |
| ID | Common name | Description | N° of binding sites | Bound to chains |
|---|---|---|---|---|
| 4 | α-D-mannopyranose-(1-3)-β-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-β-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-β-D-glucopyranose | 4 (1 molecule) | C [auth B] |
|
| 5 | β-D-mannopyranose-(1-4)-[α-D-mannopyranose-(1-6)]2-acetamido-2-deoxy-β-D-glucopyranose | 3 (1 molecule) | C, D, F [auth A,B,C] |
|
| 6 | zn-α-2-glycoprotein zag | 2-acetamido-2-deoxy-β-D-glucopyranose | 1 (1 molecule) | A [auth E] |